Filing Details
- Accession Number:
- 0001822629-24-000014
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 17:38:49
- Reporting Period:
- 2024-11-26
- Accepted Time:
- 2024-11-27 17:38:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1822629 | Nikhil Lalwani | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-11-26 | 30,000 | $29.00 | 403,859 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-11-26 | 30,000 | $57.95 | 373,859 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-11-26 | 3,481 | $58.30 | 370,378 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-11-26 | 30,000 | $29.00 | 30,000 | $29.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 138,027 | 2030-09-08 | No | 4 | M | Direct |
Footnotes
- The shares were sold in multiple trades at prices ranging from $57.76 to $58.55. The price reported above reflects the weighted average sales price.
- The shares were sold in multiple trades at prices ranging from $58.18 to $58.61. The price reported above reflects the weighted average sales price.
- 25% of the total options vested on each of September 8, 2021, September 8, 2022, September 8, 2023 and September 8, 2024.
Billionaire Hedge Funds
